Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC-01 Nasal Spray for Dry Eye Disease after Corneal Collagen Crosslinking
NCT05136924Phase 2Unknown
- Sponsor
- Vance Thompson Vision
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in dry eye disease (DED), sponsored by Vance Thompson Vision. Status: unknown.
02
Drugs
varenicline
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05136924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05136924.